FINNENCE ▪ THE WIRE FILE
THE WIRE · № 71144
News■ Unclear/unknown
IAM IPO News - Small molecule biotech Iambic Therapeutics sets terms for $150 million IPO
KINDNews
DIRECTION■ Unclear/unknown
SOURCES3
ENTITIES3
STORY SIZE3 RECORDS
FIRST SEEN2026-10-08 12:44 UTC
LAST UPDATE2026-10-08 12:45 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A $150M biotech IPO adds to the healthcare issuance pipeline, a modest signal for biotech risk appetite.
Small biotech IPO tests sector appetite
CATALYST TO WATCH
IPO pricing and first-day trading
MAIN RISK
Small deal, limited read-through
02 THE STORY SO FAR
THE RECORD, IN ORDER.
UPDATED 3 TIMES · FIRST 2026-10-08 12:08 UTC · LAST 2026-10-08 12:45 UTC2026-10-08 12:08 UTCNewsNvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO
2026-10-08 12:44 UTCNewsIAM IPO News - Small molecule biotech Iambic Therapeutics sets terms for $150 million IPOCURRENT RECORD
2026-10-08 12:45 UTCNewsIambic aims for $135M IPO to push cancer drugs through clinic
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare, XBI
Iambic aims for $135M IPO to push cancer drugs through clinic2026-10-08 12:45 UTC
Iambic aims for $135M IPO to push cancer drugs through clinic2026-10-08 12:45 UTC
→CORRELATIONshares Healthcare
Money Matters: Oil Prices Increase & Prescription Costs Rise2026-10-08 13:27 UTC
Money Matters: Oil Prices Increase & Prescription Costs Rise2026-10-08 13:27 UTC
→CORRELATIONshares Healthcare
AI drug discovery startup Iambic seeks $150M in IPO2026-10-08 13:41 UTC
AI drug discovery startup Iambic seeks $150M in IPO2026-10-08 13:41 UTC
→CORRELATIONshares Healthcare
Hormonal Facial Hair Is the Menopause Symptom No One Warns Women About2026-10-08 14:12 UTC
Hormonal Facial Hair Is the Menopause Symptom No One Warns Women About2026-10-08 14:12 UTC
→CORRELATIONshares Healthcare
Healthcare Quality Management (QMS) Market worth $2.81 billion by 20312026-10-08 14:30 UTC
Healthcare Quality Management (QMS) Market worth $2.81 billion by 20312026-10-08 14:30 UTC
→CORRELATIONshares Healthcare
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape2026-10-08 14:31 UTC
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape2026-10-08 14:31 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.